Status:
COMPLETED
Collagen-based Filler for Trapeziometacarpal Osteoarthritis
Lead Sponsor:
Azienda Ospedaliera Universitaria Integrata Verona
Conditions:
Trapeziometacarpal Osteoarthritis
Eligibility:
All Genders
18-99 years
Brief Summary
Introduction. Trapeziometacarpal osteoarthritis (TMC OA) is a degenerative condition characterized by pain, stiffness, and reduced hand function, significantly impairing daily activities. Non-surgical...
Eligibility Criteria
Inclusion
- patients with rhizarthrosis diagnosed on X-rays performed in the last year;
- patients aged \> 18 years;
- enrollment in the study through informed consent;
Exclusion
- patients who have undergone cortisone and/or hyaluronic acid infiltrations in the last 6 months;
- patients following trauma involving the ATM;
- patients with underlying rheumatological diseases;
- patients under 18 years of age
- ongoing pregnancy;
- patients affected by metabolic disorders (e.g. diabetes)
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06881186
Start Date
January 1 2021
End Date
January 1 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria Integrata
Verona, ITA, Italy, 37121